These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 390247)
21. Thromboangitis obliterans (Buerger's disease); role of sympathectomy in treatment. KLEINSASSER LJ Tex State J Med; 1953 Jan; 49(1):20-4. PubMed ID: 13029017 [No Abstract] [Full Text] [Related]
22. Association of HLA-A9 and HLA-B5 with Buerger's disease. McLoughlin GA; Helsby CR; Evans CC; Chapman DM Br Med J; 1976 Nov; 2(6045):1165-6. PubMed ID: 990826 [TBL] [Abstract][Full Text] [Related]
23. [Contribution to the cerebral form of Winiwarter-Buerger's thromboangitis obliterans]. LENZ H Wien Med Wochenschr; 1947 Apr; 97(16-17):195-7. PubMed ID: 20243320 [No Abstract] [Full Text] [Related]
30. Ergot as the cause of thromboangitis obliterans (Buerger's disease). KAUNITZ J Angiology; 1955 Dec; 6(6):556-66. PubMed ID: 13275762 [No Abstract] [Full Text] [Related]
31. Induced hypertension as a therapy in Buerger's disease (thromboangitis obliterans). Krähenbühl B; Holstein P; Nielsen SL; Tonnesen KH; Lassen NA Vasa; 1975; 4(4):407-11. PubMed ID: 1229650 [No Abstract] [Full Text] [Related]
32. Pathology and pathogenesis of Buerger's disease. Tanaka K Int J Cardiol; 1998 Oct; 66 Suppl 1():S237-42. PubMed ID: 9951825 [TBL] [Abstract][Full Text] [Related]
33. [Histologic characteristics of the pathologic processes in thromboangiitis obliterans (Buerger's disease)]. Fujimoto T; Usui N; Kakinoki E; Uemichi A; Kinoshita H Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1628-35. PubMed ID: 2263246 [TBL] [Abstract][Full Text] [Related]
34. [Histopathological contribution to the knowledge of Buerger's disease; obliterating thromboangioitis]. TROJANIELLO A Ann Ital Chir; 1948 Sep; 25(9):555-76. PubMed ID: 18108613 [No Abstract] [Full Text] [Related]
35. Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis. Heper G; Kose S; Akkoc O; Amasyali B; Kilic A Int Heart J; 2005 May; 46(3):563-9. PubMed ID: 16043952 [TBL] [Abstract][Full Text] [Related]
36. Evidence for an HLA-linked resistance gene in Buerger's disease. de Moerloose P; Jeannet M; Mirimanoff P; Bouvier CA Tissue Antigens; 1979 Aug; 14(2):169-73. PubMed ID: 91227 [TBL] [Abstract][Full Text] [Related]
37. Images in cardiovascular medicine. Corkscrew collaterals in thromboangitis obliterans (Buerger's disease). Fujii Y; Nishioka K; Yoshizumi M; Chayama K; Higashi Y Circulation; 2007 Nov; 116(21):e539-40. PubMed ID: 18025397 [No Abstract] [Full Text] [Related]
38. Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells. Sun XL; Law BY; de Seabra Rodrigues Dias IR; Mok SWF; He YZ; Wong VK Atherosclerosis; 2017 Oct; 265():258-265. PubMed ID: 28864202 [TBL] [Abstract][Full Text] [Related]
39. CAT scan and immunohistochemical findings in a case of cerebral thromboangiitis obliterans (Buerger's disease). Kessler C; Reuther R; Berlit P; Carls C; Hofmann W Eur Neurol; 1984; 23(1):7-11. PubMed ID: 6714279 [TBL] [Abstract][Full Text] [Related]
40. C3 complement components & their breakdown product (C3d) in patients of thromboangiitis obliterans. Gulati SM; Agarwal V; Sharma V; Saha K Indian J Med Res; 1986 Dec; 84():607-11. PubMed ID: 3494676 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]